Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trialResearch Published on 2024-08-092024-09-05 Journal: The British Journal of General Practice [Category] update2024, [키워드] antiviral drugs Cost-benefit analysis COVID-19 molnupiravir Quality-Adjusted Life Years SARS-CoV-2 [DOI] 10.3399/BJGP.2023.0444 PMC 바로가기 [Article Type] Research
GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitisVeterinary Science Original Research Published on 2024-07-182024-09-05 Journal: Frontiers in Veterinary Science [Category] update2024, [키워드] Feline infectious peritonitis GS-441524 molnupiravir outcomes Treatment [DOI] 10.3389/fvets.2024.1422408 PMC 바로가기 [Article Type] Veterinary Science Original Research
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort studyResearch Published on 2024-07-042024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] COVID-19 molnupiravir monoclonal antibody Nirmatrelvir/ritonavir Omicron BA.1 Omicron BA.2 Omicron BA.5 oral antivirals Sotrovimab [DOI] 10.1186/s12879-024-09576-7 PMC 바로가기 [Article Type] Research
Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disordersPharmacology Original Research Published on 2024-07-042024-09-05 Journal: Frontiers in Pharmacology [Category] update2024, [키워드] COVID-19 Hospitalization molnupiravir Mortality post-COVID-19 condition psychiatric disorder SARS-CoV-2 [DOI] 10.3389/fphar.2024.1384264 PMC 바로가기 [Article Type] Pharmacology Original Research
The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19Article Published on 2024-06-142024-09-05 Journal: bioRxiv [Category] update2024, [키워드] COVID-19 Immunocompromised intra-host evolution molnupiravir Nirmatrelvir Paxlovid SARS-CoV-2 [DOI] 10.1101/2024.02.27.582110 PMC 바로가기 [Article Type] Article
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational studyArticle Published on 2024-05-032024-09-05 Journal: EClinicalMedicine [Category] update2024, [키워드] Advanced kidney disease CKD molnupiravir Nirmatrelvir-ritonavir renal failure SARS-CoV-2 [DOI] 10.1016/j.eclinm.2024.102620 PMC 바로가기 [Article Type] Article
Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitroArticle Published on 2024-04-182024-09-05 Journal: Virus Research [Category] update2024, [키워드] Antiviral baloxavir Coinfection Influenza molnupiravir SARS-CoV-2 [DOI] 10.1016/j.virusres.2024.199371 PMC 바로가기 [Article Type] Article
Molnupiravir Real-World Utilization in COVID-19 Patients in the Czech RepublicArticle Published on 2024-04-162024-09-05 Journal: Journal of Clinical Medicine [Category] update2024, [키워드] COVID-19 Czech Republic molnupiravir real-world data SARS-CoV-2 treatment of COVID-19 [DOI] 10.3390/jcm13082303 PMC 바로가기 [Article Type] Article
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective studyResearch Published on 2024-04-082024-09-05 Journal: BMC Nephrology [Category] update2024, [키워드] COVID-19 kidney transplant recipients molnupiravir Remdesivir [DOI] 10.1186/s12882-024-03561-7 PMC 바로가기 [Article Type] Research
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer PatientsArticle Published on 2024-03-052024-09-05 Journal: Cancers [Category] update2024, [키워드] Cancer Coronaviruses COVID-19 Immunocompromised molnupiravir Nirmatrelvir/ritonavir Paxlovid SARS-CoV-2 therapy Treatment [DOI] 10.3390/cancers16051055 PMC 바로가기 [Article Type] Article